Profile
Yuko Amizaki joined Burrill & Company as Business Analyst in 2011.
Yuko provides support for the decision making processes associated specifically with biogreentech and the Malaysian Life Sciences Capital Fund investments, and more generally in the life sciences.
Yuko recently graduated from MIT Sloan School of Management with an MBA.
She worked in corporate planning at Regimmune, a drug development biotech in Mountain View, CA.
Previously, she was a consultant at Booz and Company in Tokyo, Japan.
She holds a master of science in biology and bachelor of agriculture in applied life science.
Former positions of Yuko Amizaki
| Companies | Position | End |
|---|---|---|
REGiMMUNE Corp.
 REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Corporate Officer/Principal | 30/10/2008 |
Booz Allen Hamilton, Inc.
 Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Corporate Officer/Principal | 31/12/2004 |
| GEMINI CORPORATION | Corporate Officer/Principal | 31/12/2002 |
Burrill LLC
 Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Corporate Officer/Principal | - |
Training of Yuko Amizaki
| Massachusetts Institute of Technology | Masters Business Admin |
| University of Tokyo | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Gemini Corp.
 Gemini Corp. Engineering & ConstructionIndustrial Services Gemini Corp. engages in the provision of professional services in the field of energy and industrial facilities. It specializes in asset acquisition, environmental and regulatory support, engineering, fabrication construction, maintenance, turnarounds, de-commissioning, reclamation and remediation. It operates through the following segments: Field Solutions, Engineered Solutions, and Environmental Solutions. The Field Solutions segment refers to installation and facility maintenance such as physical construction, upgrade or maintenance of oil and gas facilities. The Engineered Solutions segment relates to design engineering, procurement, project management services from concept to completion of projects. The Environmental Solutions concentrates on providing clients with regulatory and environmental advisory services focused on supporting project initiation and incident response requirements. The company was founded on 1982 and is headquartered in Calgary, Canada. | Industrial Services |
Burrill LLC
Burrill LLC Investment ManagersFinance Burril LLC (Burrill) is a private equity/venture capital firm founded in 1994 by G. Steven. The firm is headquartered in San Francisco, California. | Finance |
Booz Allen Hamilton, Inc.
Booz Allen Hamilton, Inc. Engineering & ConstructionIndustrial Services Booz Allen Hamilton, Inc. engages in the provision of management and technology consulting services. Its services include consulting, analytics, digital solutions, engineering, cyber security, and product. The company was founded by Edwin G. Booz in 1914 and is headquartered in McLean, VA. | Industrial Services |
REGiMMUNE Corp.
REGiMMUNE Corp. Pharmaceuticals: MajorHealth Technology REGiMMUNE Corp. develops solutions for treating immune disorders. Its focus is on the discovery, development, and commercialization of immune regulatory therapeutics to treat life-threatening and debilitating conditions, including allergies, autoimmune diseases and transplantation. The firm's platform technology, reVax, induces immune tolerance in an antigen-specific manner through pharmacological induction of regulatory T (Treg) cells. It also develops products for preventing inhibitor formation in enzyme replacement therapies (ERT) and for celiac disease with undisclosed partners. The company was founded by Yasuyuki Ishii on March 3, 2006 and is headquartered in Tokyo, Japan. | Health Technology |
- Stock Market
- Insiders
- Yuko Amizaki
